UK Judge Rules J&J Alzheimer Patent Invalid

Law360, New York (June 25, 2013, 6:47 PM EDT) -- A U.K. judge has ruled that a patent held by a Johnson & Johnson unit that is related to a potential treatment for Alzheimer's disease is invalid, siding with pharmaceutical maker Eli Lilly & Co., which challenged the patent, officials confirmed.

Judge Richard Arnold deemed the patent held by J&J's Janssen Alzheimer Immunotherapy Research & Development LLC invalid, according to a Bloomberg report published Tuesday. A copy of Judge Arnold's decision was not immediately available.

“We are disappointed by the outcome of this case, and we...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.